PillRx only · Injection, Solution · Infiltration
Lidocaine Hydrochloride And Epinephrine
Brands: Xylocaine · Epinephrine + Lidocaine Hydrochloride
5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US15 NDCs
5 active makers
5 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.139
Latest avg · Jul 22, 2026
+0%
Since May 20, 2026
5
Active US suppliers
83%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
7.6K
Rx · 2026 Q1
201K
Units dispensed
-10%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it5 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Henry Schein Inc. | unknown | 11 | SUPPLYING |
| Hospira, Inc. | unknown | 9 | SUPPLYING |
| Sportpharm LLC | unknown | 2 | SUPPLYING |
| ProPharma Distribution | unknown | 1 | SUPPLYING |
| Cardinal Health 107, LLC | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 22, 2012SHORTAGEDrug shortage: Epinephrine Bitartrate, Lidocaine Hydrochloride Injection (Hospira, Inc., a Pfizer Company)
Epinephrine Bitartrate, Lidocaine Hydrochloride Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Anesthesia, Pediatric.